These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 12089882)
1. [Usefulness of osteocalcin and CrossLaps as markers of bone turnover in children with chronic renal failure]. Polak-Jonkisz D; Zwolińska D; Bednorz R; Owczarek H; Nahaczewska W Pol Merkur Lekarski; 2002 Apr; 12(70):257-60. PubMed ID: 12089882 [TBL] [Abstract][Full Text] [Related]
2. Procollagen I carboxyterminal propeptide (PICP) as a bone formation marker and carboxyterminal telopeptide of type I collagen (ICTP) as a bone degradation marker in children with chronic renal failure under conservative therapy. Polak-Jonkisz D; Zwolińska D; Bednorz R; Owczarek H; Szymańska A; Nahaczewska W Med Sci Monit; 2003 Jan; 9(1):CR19-23. PubMed ID: 12552245 [TBL] [Abstract][Full Text] [Related]
3. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children. Baskin E; Beşbaş N; Saatçi U; Hasçelik G; Topaloğlu R; Ozen S; Bakkaloğlu A Turk J Pediatr; 2004; 46(1):28-31. PubMed ID: 15074371 [TBL] [Abstract][Full Text] [Related]
4. Serum crosslaps in comparison to serum osteocalcin and urinary bone resorption markers. Peichl P; Griesmacherb A; Marteau R; Hejc S; Kumpan W; Müller MM; Bröll H Clin Biochem; 2001 Mar; 34(2):131-9. PubMed ID: 11311223 [TBL] [Abstract][Full Text] [Related]
5. Significance of Bio-intact PTH(1-84) assay in hemodialysis patients. Inaba M; Okuno S; Imanishi Y; Ueda M; Yamakawa T; Ishimura E; Nishizawa Y Osteoporos Int; 2005 May; 16(5):517-25. PubMed ID: 15322741 [TBL] [Abstract][Full Text] [Related]
6. [Diagnostic value of PTH total kit for estimation of bone turnover in children with chronic renal failure]. Ziółkowska H; Roszkowska-Blaim M Przegl Lek; 2006; 63 Suppl 3():149-52. PubMed ID: 16898516 [TBL] [Abstract][Full Text] [Related]
7. [Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis]. Nowak Z; Konieczna M; Wańkowicz Z Pol Merkur Lekarski; 2004 Aug; 17(98):138-41. PubMed ID: 15603322 [TBL] [Abstract][Full Text] [Related]
8. [Blood serum osteocalcin and beta-crosslaps concentrations in patients after renal transplantation]. Zbróg Z; Tomaszek M; Szuflet A; Pierzchalska-Mudyna T; Rybińska A; Skrzypek A; Matych J Przegl Lek; 2007; 64(6):431-4. PubMed ID: 18159853 [TBL] [Abstract][Full Text] [Related]
9. [Serum osteocalcin in children with chronic renal insufficiency]. Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853 [TBL] [Abstract][Full Text] [Related]
10. Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis? Avbersek-Luznik I; Balon BP; Rus I; Marc J Nephrol Dial Transplant; 2005 Mar; 20(3):566-70. PubMed ID: 15665031 [TBL] [Abstract][Full Text] [Related]
11. [Serum beta-type I collagen carboxyterminal telopeptide (beta-CTXs) and bone involvement in chronic renal failure]. Oliveri B; Wittich AC; Nadal MA; Zeni SN Medicina (B Aires); 2005; 65(4):321-8. PubMed ID: 16193710 [TBL] [Abstract][Full Text] [Related]
12. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients. Małyszko J; Małyszko JS; Pawlak K; Wołczyński S; Myśliwiec M Adv Med Sci; 2006; 51():69-72. PubMed ID: 17357281 [TBL] [Abstract][Full Text] [Related]
13. [Skeletal scintigraph and some bone turnover markers in the diagnosis of renal osteodystrophy in hemodialysis patients]. Bednarek-Skublewska A; Chrapko B; Ksiazek A Pol Arch Med Wewn; 2003 Sep; 110(3):943-50. PubMed ID: 14699686 [TBL] [Abstract][Full Text] [Related]
15. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis. Kotzmann H; Riedl M; Pietschmann P; Schmidt A; Schuster E; Kreuzer S; Kainberger F; Frisch H; Geyer G; Hörl WH; Mayer G; Luger A J Nephrol; 2004; 17(1):87-94. PubMed ID: 15151263 [TBL] [Abstract][Full Text] [Related]
16. Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure. López Gavilanes E; González Parra E; de la Piedra C; Caramelo C; Rapado A Miner Electrolyte Metab; 1994; 20(5):259-64. PubMed ID: 7700213 [TBL] [Abstract][Full Text] [Related]
17. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Rix M; Andreassen H; Eskildsen P; Langdahl B; Olgaard K Kidney Int; 1999 Sep; 56(3):1084-93. PubMed ID: 10469378 [TBL] [Abstract][Full Text] [Related]
18. [Correlation between osteocalcin and bone histomorphometry in children with chronic renal failure]. Weglarska J; Ziółkowska H; Pańczyk-Tomaszewska M; Sieniawska M Pediatr Pol; 1995 Dec; 70(12):1011-5. PubMed ID: 8649939 [TBL] [Abstract][Full Text] [Related]
19. Relationship between plasma levels of sclerostin, calcium-phosphate disturbances, established markers of bone turnover, and inflammation in haemodialysis patients. Pietrzyk B; Wyskida K; Ficek J; Kolonko A; Ficek R; Więcek A; Olszanecka-Glinianowicz M; Chudek J Int Urol Nephrol; 2019 Mar; 51(3):519-526. PubMed ID: 30584645 [TBL] [Abstract][Full Text] [Related]
20. Correlations of new markers of bone formation and resorption in kidney transplant recipients. Małyszko J; Wołczyński S; Małyszko JS; Konstantynowicz J; Kaczmarski M; Myśliwiec M Transplant Proc; 2003 Jun; 35(4):1351-4. PubMed ID: 12826157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]